These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. [Hepatotoxicity of laxatives. Further results due to exposure to phenolisatines and bisacodyl]. Henning H; Vogel HM; von Braun HH Z Gastroenterol; 1974 Feb; 12(1):15-8. PubMed ID: 4440042 [No Abstract] [Full Text] [Related]
23. [Drug- and toxin-induced hepatotoxicity]. Grünhage F; Fischer HP; Sauerbruch T; Reichel C Z Gastroenterol; 2003 Jun; 41(6):565-78. PubMed ID: 12806543 [TBL] [Abstract][Full Text] [Related]
24. [Agranulocytosis and toxic hepatic dystrophy during treatment with tuberculostatic drugs]. Rabina EV; Semichastnova AG; Golubiatnikova GA Arkh Patol; 1972; 34(8):75-7. PubMed ID: 4345581 [No Abstract] [Full Text] [Related]
25. Letter: Hepatic necrosis after enflurane anesthesia. Van der Reis L; Askin SJ; Frecker GN; Fitzgerald WJ JAMA; 1974 Jan; 227(1):76. PubMed ID: 4859632 [No Abstract] [Full Text] [Related]
26. Drug hepatotoxicity. Nathwani RA; Kaplowitz N Clin Liver Dis; 2006 May; 10(2):207-17, vii. PubMed ID: 16971258 [TBL] [Abstract][Full Text] [Related]
28. [Digestive disorders due to drugs. II. Hepatic and pancreatic lesions]. Caulin C Presse Med (1893); 1971 Nov; 79(49):2230-7. PubMed ID: 4945345 [No Abstract] [Full Text] [Related]
29. [Classification and diagnostic strategies of drug-induced hepatic disease]. Li YM Zhonghua Gan Zang Bing Za Zhi; 2004 Jul; 12(7):445-6. PubMed ID: 15268822 [No Abstract] [Full Text] [Related]
30. [Cholestasis induced by roxithromycin in a patient with a past history of pregnancy intrahepatic cholestasis]. Gross R; Mion F; Paliard P Gastroenterol Clin Biol; 1993; 17(2):146-7. PubMed ID: 8500706 [No Abstract] [Full Text] [Related]
32. Editorial: Halothane and liver damage. Br Med J; 1974 Sep; 3(5931):589-90. PubMed ID: 4423092 [No Abstract] [Full Text] [Related]
33. Severe ductopenia and cholestasis from levofloxacin drug-induced liver injury: a case report and review. Levine C; Trivedi A; Thung SN; Perumalswami PV Semin Liver Dis; 2014 May; 34(2):246-51. PubMed ID: 24879988 [TBL] [Abstract][Full Text] [Related]
34. [Hepatotoxicity of antituberculosis drugs: practical implications for monitoring]. Durand F; Bernuau J; Pessayre D Gastroenterol Clin Biol; 1998 Feb; 22(2):117-20. PubMed ID: 9762183 [No Abstract] [Full Text] [Related]
35. Withdrawal of oxyphenisatin acetate, diacetoxydiphenolisatin and triacetyldiphenolisatin from the Australian market. Med J Aust; 1972 May; 1(20):1051-3. PubMed ID: 5056305 [No Abstract] [Full Text] [Related]
36. Tamoxifen-induced submassive hepatic necrosis. Storen EC; Hay JE; Kaur J; Zahasky K; Hartmann L Cancer J; 2000; 6(2):58-60. PubMed ID: 11069218 [No Abstract] [Full Text] [Related]
37. [The liver and drugs]. Nicolae B; Neamţu L Rev Med Interna Neurol Psihiatr Neurochir Dermatovenerol Med Interna; 1983; 35(2):97-106. PubMed ID: 6139865 [No Abstract] [Full Text] [Related]
38. [Liver and antitubercular drug therapy]. Viroglio AL; Piñeyro JO; Acosta A; Munaro N; Escarguel Malbrán J; Pérez JA Rev Fac Cienc Med Cordoba; 1974; 32(1):19-36. PubMed ID: 4458009 [No Abstract] [Full Text] [Related]
39. [Clinical case of the month. Hepatoportal sclerosis in a patient treated with azathioprine]. Roland S; Delwaide J; Cornet G; Mahieu P; Jacquet N; Belaiche J Rev Med Liege; 1998 Aug; 53(8):450-3. PubMed ID: 9810203 [TBL] [Abstract][Full Text] [Related]